Research field (2):
Neurology
, Experimental pathology
Research keywords (4):
Clinical Trials
, Clinical Research
, Neuropathology
, Alzheimer's Disease
Research theme for competitive and other funds (2):
2024 - 2028 特性に基づく非アルツハイマー病の分類と超早期の臨床的特徴の検討
2022 - 2025 心房細動アブレーションによる洞調律化が認知機能に与える効果の解明
Papers (34):
Ryosuke Shimasaki, Masanori Kurihara, Keiko Hatano, Ryoji Goto, Kenichiro Taira, Ryoko Ihara, Mana Higashihara, Yasushi Nishina, Masashi Kameyama, Atsushi Iwata. Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses. Parkinsonism & Related Disorders. 2024. 128. 107129-107129
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Kazushi Suzuki, Kiyotaka Nemoto, Tetsuaki Arai, Shinji Higashi, Ataru Igarashi, Kensaku Kasuga, et al. Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan. Alzheimer's research & therapy. 2024. 16. 1. 205-205
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Takeshi Iwatsubo. Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value. Journal of Alzheimer's disease : JAD. 2024
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Takeshi Iwatsubo. Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease Treatment. Biomedicines. 2024. 12. 8
Soichiro Kondo, Kenji Ishibashi, Kenji Ishii, Atsushi Iwata, Ryoko Ihara. Clinical Application of 18F-THK5351 PET to Image Ongoing Astrogliosis in MSA-P and MSA-C. Clinical nuclear medicine. 2024